New Delhi, Nov. 9 -- The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers, has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs, based on the recommendations of an Expert Committee constituted by the Directorate General of Health Services (DGHS), Ministry of Health & Family Welfare, on October 17, 2026.

According to a press release issued by the Ministry of Chemicals and Fertilisers, the revised MRPs of these medicines come into effect from today.

As on 8th of November, 2026, 85 Pharmaceutical Companies have reported revised MRPs for 1,364 anti-cancer formulations, covering 121 drugs. With 679 brands reporting price reductions ...